相关实验视频
Updated: Jul 19, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
唾液腺癌的放射治疗:通过正式的共识方法推REFCOR建议
J Thariat1, F-R Ferrand2, N Fakhry3
1Département de radiothérapie, centre François-Baclesse, Caen, France.
European annals of otorhinolaryngology, head and neck diseases
|November 29, 2023
概括
唾液腺癌的放射治疗建议在手术后对具有不良基因预后因素的患者进行放射治疗,例如晚期瘤阶段或积极边缘. 强度调节放射治疗 (IMRT) 是首选的疗法.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 头部和部癌症 头部和部癌症
背景情况:
- 唾液腺癌很少见,但可能有侵略性行为.
- 确定放射治疗的适当指示对于改善患者的治疗结果至关重要.
- 目前针对这些癌症进行放射治疗的指导方针需要明确的定义.
研究的目的:
- 确定在唾液腺癌中进行放射治疗的指示.
- 指定推的辐射方式和目标体积.
- 为临床实践制定基于证据的建议.
主要方法:
- 对Medline出版的文学进行了叙事审查.
- 建议由法国罕见头瘤网络 (REFCOR) 的指导小组起草.
- 使用正式的共识方法评估了遵守建议的情况.
主要成果:
- 术后放射治疗适用于唾液腺癌,具有不良的组织预后因素 (例如T3-T4,淋巴结入侵,临近边缘).
- 强度调节辐射疗法 (IMRT) 是黄金标准的疗法.
- 对于不可切除或不可手术的病例,可以考虑碳离子哈德龙疗法.
结论:
- 放射治疗适用于术后的唾液腺癌,当存在不良的基因预后因素时.
- 放射治疗也适用于无法手术的唾液腺瘤.
- 这些建议旨在优化唾液腺癌的治疗策略.
更多相关视频
07:44Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction
Published on: April 24, 2016
11.4K
07:38Radiation Treatment of Organotypic Cultures from Submandibular and Parotid Salivary Glands Models Key In Vivo Characteristics
Published on: May 17, 2019
8.2K
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...